表紙
市場調査レポート

カナダの小児用ワクチン市場、用量、予防接種、事例、予測

Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast

発行 Renub Research 商品コード 328161
出版日 ページ情報 英文 104 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
カナダの小児用ワクチン市場、用量、予防接種、事例、予測 Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast
出版日: 2015年04月13日 ページ情報: 英文 104 Pages
概要

カナダの小児用ワクチン市場は、2020年までに20億米ドル規模に近づくことが予測されています。

当レポートでは、カナダの小児用ワクチン市場について調査分析し、市場の概要、現状と予測、事例、用量、予防接種範囲、成長促進要因と課題などについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 カナダの小児用ワクチン市場と予測

第3章 カナダの小児用ワクチン市場シェアと予測

第4章 カナダの小児用ワクチン事例、用量、予防接種範囲、市場と予測

  • カナダ:はしか、おたふく風邪、風疹 (MMR) ワクチンと予測
  • カナダ:ヘモフィラス・インフルエンザ菌タイプB (Hib) ワクチンと予測
  • カナダ:ポリオワクチンと予測
  • カナダ:ジフテリア・百日咳・破傷風 (DPT) ワクチンと予測
  • カナダ:肺炎球菌ワクチンと予測
  • カナダ:B型肝炎小児用ワクチンと予測
  • カナダ:水痘ワクチンと予測
  • カナダ:髄膜炎菌ワクチンと予測

第5章 カナダの小児用ワクチン市場の成長促進要因

  • 予防接種と予防可能な感染症を減らす
  • ワクチン傷害補償プログラム
  • ワクチン技術の転換
  • 効果的なコミュニケーション戦略

第6章 カナダの小児用ワクチン市場の課題

  • 研究開発の障害
  • 新規参入への障壁
  • 認可ワクチン使用への障害
  • ワクチン開発と承認システムの複雑さ
  • ワクチン開発予定表の短縮

図表

目次

Pediatric vaccines market continues to be the success story for the manufacturers of pediatric vaccines in Canada. The value of the Canada pediatric vaccines market is expected to be slightly less than US$ 2 Billion by 2020. Pneumococcal vaccines (PCV) and Varicella vaccines are the leading market share holder in Canada and together they contribute more than 50% of the total Pediatric vaccines market. Polio, Measles, Mumps & Rubella (MMR), Diphtheria, Tetanus & Pertussis (DTaP) cases have shown diminishing trends from the year 2001 till 2013.

On the contrary, in terms of Doses, Diphtheria, Tetanus & Pertussis(DTaP) and Pneumococcal vaccines (PCV) have the highest number of doses in 2014.Diphtheria, Tetanus & Pertussis(DTap) and Polio are the highly penetrated vaccines in Canada pediatric vaccines market in 2014. It is predicted that these two vaccines will bolster the usable pattern in Canada. Canada Pediatric vaccines are expected to remain highly active in the future, fueled by the encouragement and financing from Governments and other health organizations. Canada Pediatric vaccines market is driven by favorable demographics, growing public acceptance and product innovation.

This is Renub Research 7th edition report on Vaccines Market & 2nd edition on Pediatric Vaccines Sector. Report titled “Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast” talks about the pediatric vaccines scenario in Canada. This report provides information on Eight (8) segments of Pediatric Vaccines Market, Pediatric Vaccines Doses, Pediatric Vaccines number of Children Being Vaccinated and Number of Cases in Canada. This report covers in detail all aspects of Past, Present and Future Scenario. The report also entails major factors driving the Pediatric Vaccines Market and Challenges of Canada Pediatric Vaccines Market.

8 Pediatric Vaccines Covered in this Report are as follows:

  • 1. Measles, Mumps & Rubella (MMR) Vaccines
  • 2. Haemophilus Influenzae Type B (HIB) Vaccines
  • 3. Polio Vaccines
  • 4. Diphtheria, Tetanus & Pertussis (DTaP) Vaccines
  • 5. Pneumococcal Vaccines
  • 6. Hepatitis B Pediatric Vaccines
  • 7. Varicella / Chicken Pox Vaccines
  • 8. Meningococcal C Conjugate (Men-C) Vaccines

All the Pediatric Vaccines in this Report have been studied from Four View Points:

  • Number of Cases
  • Number of Doses
  • Number of Children Being Vaccinated
  • Market Size for all 8 Pediatric Vaccines

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government websites, Trade Journals, White Papers, Government Agencies, Magazines, Newspapers, Trade Associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. Canada - Pediatric Vaccines Market & Forecast

3. Canada - Pediatric Vaccines Market Share & Forecast

4. Canada - Pediatric Vaccines Cases, Doses, Immunization Coverage, Market & Forecast

  • 4.1. Canada - Measles, Mumps & Rubella (MMR) Vaccines & Forecast
    • 4.1.1. Number of Measles, Mumps & Rubella (MMR) Cases
    • 4.1.2. Number of Measles, Mumps & Rubella (MMR) Vaccines Doses
    • 4.1.3. Measles, Mumps & Rubella (MMR) - Number of Children Being Vaccinated
    • 4.1.4. Market Size of Measles, Mumps & Rubella (MMR) Vaccines
  • 4.2. Canada - Haemophilus Influenzae Type B (HIB) Vaccines & Forecast
    • 4.2.1. Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses
    • 4.2.2. Haemophilus Influenzae Type B (HIB) - Number of Children Being Vaccinated
    • 4.2.3. Market Size of Haemophilus Influenzae Type B (HIB) Vaccines
  • 4.3. Canada - Polio Vaccines & Forecast
    • 4.3.1. Number of Polio Cases
    • 4.3.2. Number of Polio Vaccines Doses
    • 4.3.3. Polio Vaccines - Number of Children Being Vaccinated
    • 4.3.4. Market Size of Polio Vaccines
  • 4.4. Canada - Diphtheria, Tetanus & Pertussis (DTaP) Vaccines & Forecast
    • 4.4.1. Number of Diphtheria, Tetanus & Pertussis (DTaP) Cases
    • 4.4.2. Number of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Doses
    • 4.4.3. Diphtheria, Tetanus & Pertusis (DTaP) - Number of Children Being Vaccinated
    • 4.4.4. Market Size of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines
  • 4.5. Canada - Pneumococcal Vaccines & Forecast
    • 4.5.1. Number of Pneumococcal Vaccines Doses
    • 4.5.2. Pneumococcal - Number of Children Being Vaccinated
    • 4.5.3. Market Size of Pneumococcal Vaccines
  • 4.6. Canada - Hepatitis B Pediatric Vaccines & Forecast
    • 4.6.1. Number of Hepatitis B Pediatric Vaccines Doses
    • 4.6.2. Hepatitis B Pediatric - Number of Children Being Vaccinated
    • 4.6.3. Market Size of Hepatitis B Pediatric Vaccines
  • 4.7. Canada - Varicella / Chicken Pox Vaccines & Forecast
    • 4.7.1. Number of Varicella / Chicken Pox Vaccines Doses
    • 4.7.2. Varicella / Chicken Pox - Number of Children Being Vaccinated
    • 4.7.3. Market Size of Varicella / Chicken Pox Vaccines
  • 4.8. Canada - Meningococcal C (Men-C) Vaccines & Forecast
    • 4.8.1. Number of Meningococcal C (Men-C) Vaccines Doses
    • 4.8.2. Meningococcal C (Men-C) - Number of Children Being Vaccinated
    • 4.8.3. Market Size of Meningococcal C (Men-C) Vaccines

5. Growth Drivers of Canada Pediatric Vaccines Market

  • 5.1. Immunization & Reduce Preventable Infectious Diseases
    • 5.1.1. Immunization - a Collective Protection
    • 5.1.2. Immunization in Public Health - Past & Present
    • 5.1.3. Immunization-a Shared Responsibility
  • 5.2. The Vaccine Injury Compensation Program
  • 5.3. Transforming of Vaccine Technologies
  • 5.4. Continuous Focus on Effective Communication Strategies

6. Challenges of Canada Pediatric Vaccines Market

  • 6.1. Impediment in Pediatric Vaccine Research & Development
  • 6.2. Barriers to New Entrants in the Pediatric Vaccines Market
  • 6.3. Hurdles to Optimal use of Licensed Vaccines
    • 6.3.1. Technical Obstacles
    • 6.3.2. Economic obstacles
    • 6.3.3. Cultural Obstacles
  • 6.4. Complexity of Vaccine Development & Approval System Thwarts Product Development
    • 6.4.1. Legal Obstacles
    • 6.4.2. General Technical Barriers
    • 6.4.3. Economic Barriers
    • 6.4.4. Regulatory Barriers
  • 6.5. Shortening the Timeline for Vaccine Development

LIST OF FIGURES

  • Figure 2-1: Canada - Pediatric Vaccines Market (Million US$), 2010 - 2014
  • Figure 2-2: Canada - Forecast for Pediatric Vaccines Market (Million US$), 2015 - 2020
  • Figure 3-1: Canada - Pediatric Vaccines Market Share (Percent), 2010 - 2014
  • Figure 3-2: Canada - Forecast for Pediatric Vaccines Market Share (Percent), 2015 - 2020
  • Figure 4-1: Canada - Number of MMR Vaccines Doses (Million Doses), 2010 - 2014
  • Figure 4-2: Canada - Forecast for Number of MMR Vaccines Doses (Million Doses), 2015 - 2020
  • Figure 4-3: Canada - Number of Children Being Vaccinated with MMR Vaccines (Million), 2010 - 2014
  • Figure 4-4: United States - Forecast for Number of Children Being Vaccinated with MMR Vaccines (Million), 2015 - 2020
  • Figure 4-5: Canada - Measles, Mumps & Rubella (MMR) Vaccines Market (Million US$), 2010 - 2014
  • Figure 4-6: Canada - Forecast for Measles, Mumps & Rubella (MMR) Vaccines Market (Million US$), 2015 - 2020
  • Figure 4-7: Canada - Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2010 - 2014
  • Figure 4-8: Canada - Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2015 - 2020
  • Figure 4-9: Canada - Number of Children Being Vaccinated with Haemophilus Influenzae Type B Vaccines (Million), 2010 - 2014
  • Figure 4-10: Canada - Forecast for Number of Children Being Vaccinated with Haemophilus Influenzae Type B Vaccines (Million), 2015 - 2020
  • Figure 4-11: Canada - Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2010 - 2014
  • Figure 4-12: Canada - Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2015 - 2020
  • Figure 4-13: Canada - Number of Doses of Polio Vaccines (Million Doses), 2010 - 2014
  • Figure 4-14: Canada - Forecast for Number of Doses of Polio Vaccines (Million Doses), 2015 - 2020
  • Figure 4-15: Canada - Number of Children Being Vaccinated with Polio Vaccines (Million), 2010 - 2014
  • Figure 4-16: Canada - Forecast for Number of Children Being Vaccinated with Polio Vaccines (Million), 2015 - 2020
  • Figure 4-17: Canada - Polio Vaccines Market (Million US$), 2010 - 2014
  • Figure 4-18: Canada - Forecast for Polio Vaccines Market (Million US$), 2015 - 2020
  • Figure 4-19: Canada - Number of Doses of DTaP Vaccines (Million Doses), 2010 - 2014
  • Figure 4-20: Canada - Forecast for Number of Doses of DTaP Vaccines (Million Doses), 2015 - 2020
  • Figure 4-21: Canada - Number of Children Being Vaccinated with DTaP Vaccines (Million Doses), 2010 - 2014
  • Figure 4-22: Canada - Forecast for Number of Children Being Vaccinated with DTap Vaccines (Million Doses), 2015 - 2020
  • Figure 4-23: Canada - Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million US$), 2010 - 2014
  • Figure 4-24: Canada - Forecast for Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million US$), 2015 - 2020
  • Figure 4-25: Canada - Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 - 2014
  • Figure 4-26: Canada - Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2015 - 2020
  • Figure 4-27: Canada - Number of Children Being Vaccinated with Pneumococcal Vaccines (Million), 2010 - 2014
  • Figure 4-28: Canada - Forecast for Number of Children Being Vaccinated with Pneumococcal Vaccines (Million), 2015 - 2020
  • Figure 4-29: Canada - Pneumococcal Vaccines Market (Million US$), 2010 - 2014
  • Figure 4-30: Canada - Forecast for Pneumococcal Vaccines Market (Million US$), 2015 - 2020
  • Figure 4-31: Canada - Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses), 2010 - 2014
  • Figure 4-32: Canada - Forecast for Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses), 2015 - 2020
  • Figure 4-33: Canada - Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines (Million), 2010 - 2014
  • Figure 4-34: Canada - Forecast for Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines (Million), 2015 - 2020
  • Figure 4-35: Canada - Hepatitis B Pediatric Vaccines Market (Million US$), 2010 - 2014
  • Figure 4-36: Canada - Forecast for Hepatitis B Pediatric Vaccines Market (Million US$), 2015 - 2020
  • Figure 4-37: Canada - Number of Doses of Varicella Vaccines (Million Doses), 2010 - 2014
  • Figure 4-38: Canada - Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2015 - 2020
  • Figure 4-39: Canada - Number of Children Being Vaccinated with Varicella Vaccines (Million), 2010 - 2014
  • Figure 4-40: Canada - Forecast for Number of Children Being Vaccinated with Varicella Vaccines (Million), 2015 - 2020
  • Figure 4-41: Canada - Varicella Vaccines Market (Million US$), 2010 - 2014
  • Figure 4-42: Canada - Forecast for Varicella Vaccines Market (Million US$), 2015 - 2020
  • Figure 4-43: Canada - Number of Doses of Meningococcal C (Men-C) Vaccines (Million Doses), 2010 - 2014
  • Figure 4-44: Canada - Forecast for Number of Doses of Meningococcal C (Men-C) Vaccines (Million Doses), 2015 - 2020
  • Figure 4-45: Canada - Number of Children Being Vaccinated with Meningococcal C (Men-C) Vaccines (Million), 2010 - 2014
  • Figure 4-46: Canada - Forecast for Number of Children Being Vaccinated with Meningococcal C (Men-C) Vaccines (Million), 2015 - 2020
  • Figure 4-47: Canada - Meningococcal C (Men-C) Vaccines Market (Million US$), 2010 - 2014
  • Figure 4-48: Canada - Forecast for Meningococcal C (Men-C) Vaccines Market (Million US$), 2015 - 2020

LIST OF TABLES

  • Table 4-1: Canada - Number of Measles Cases (Number), 1999 - 2013
  • Table 4-2: Canada - Number of Mumps Cases (Number), 1999 - 2013
  • Table 4-3: Canada - Number of Rubella Cases (Number), 1999 - 2013
  • Table 4-4: Canada - Number of Polio Cases (Number), 2001 - 2013
  • Table 4-5: Canada - Number of Diphtheria Cases (Number), 1999 - 2013
  • Table 4-6: Canada - Number of nTetanus Cases (Number), 1999 - 2013
  • Table 4-7: Canada - Number of tTetanus Cases (Number), 1999 - 2013
  • Table 4-8: Canada - Number of Pertussis Cases (Number), 1999 - 2013
  • Table 5-1: Canada - Incidence of Selected Vaccine-preventable Disease, Pre-vaccine era compared with Pre-Vaccine Era to 2013
  • Table 5-2: Improvement Strategies or Requirements - the Joint Commission and the Project's Collaborating Organizations
Back to Top